| GA20093-1mg |
|
434897-64-0 |
(Des-Bromo)-Neuropeptide B (1-23) (human)
|
0 |
C107H162N30O30 |
|
|
|
| GA20092-100mg |
|
56317-01-2 |
|
0 |
C58H84N16O11 |
|
|
|
| GA20092-25mg |
|
56317-01-2 |
|
0 |
C58H84N16O11 |
|
|
|
| GA20091-100mg |
|
64695-06-3 |
(Des-Arg⁹,Leu⁸)-Bradykinin
|
0 |
C41H63N11O10 |
|
|
|
| GA20091-25mg |
|
64695-06-3 |
(Des-Arg⁹,Leu⁸)-Bradykinin
|
0 |
C41H63N11O10 |
|
|
|
| GA20090-25mg |
|
290312-22-0 |
|
0 |
C42H50N8O5 |
|
|
|
| GA20090-5mg |
|
290312-22-0 |
|
0 |
C42H50N8O5 |
|
|
|
| GA20089-5mg |
|
53697-27-1 |
|
0 |
C75H107N21O18S |
|
|
|
| GA20089-1mg |
|
53697-27-1 |
|
0 |
C75H107N21O18S |
|
|
|
| GA20088-1mg |
|
142061-53-8 |
(Deamino-Phe¹⁹,D-Ala²⁴,D-Pro²⁶-psi(CH₂NH)Phe²⁷)-GRP (19-27) (human, porcine, canine)
|
0 |
C57H72N14O8 |
|
|
|
| GA20088-005mg |
|
142061-53-8 |
(Deamino-Phe¹⁹,D-Ala²⁴,D-Pro²⁶-psi(CH₂NH)Phe²⁷)-GRP (19-27) (human, porcine, canine)
|
0 |
C57H72N14O8 |
|
|
|
| GA20087-5mg |
|
64158-84-5 |
(Deamino-Pen¹,Val⁴,D-Arg⁸)-Vasopressin
|
0 |
C48H69N13O11S2 |
|
|
|
| GA20087-1mg |
|
64158-84-5 |
(Deamino-Pen¹,Val⁴,D-Arg⁸)-Vasopressin
|
0 |
C48H69N13O11S2 |
|
|
|
| GA20086-5mg |
|
67269-08-3 |
(Deamino-Pen¹,Tyr(Me)²,Arg⁸)-Vasopressin
|
0 |
C49H70N14O12S2 |
|
|
|
| GA20086-1mg |
|
67269-08-3 |
(Deamino-Pen¹,Tyr(Me)²,Arg⁸)-Vasopressin
|
0 |
C49H70N14O12S2 |
|
|
|
| GA20085-5mg |
|
613222-50-7 |
(Deamino-Cys³,Nle⁴,Arg⁵,D-2-Nal⁷,Cys¹¹)-α-MSH (3-11) amide
|
0 |
C56H76N18O9S2 |
|
|
|
| GA20085-1mg |
|
613222-50-7 |
(Deamino-Cys³,Nle⁴,Arg⁵,D-2-Nal⁷,Cys¹¹)-α-MSH (3-11) amide
|
0 |
C56H76N18O9S2 |
|
|
|
| GA20084-5mg |
|
500170-27-4 |
(Deamino-Cys¹,β-cyclohexyl-Ala⁴,Arg⁸)-Vasopressin
|
0 |
C50H71N13O11S2 |
|
|
|
| GA20084-1mg |
|
500170-27-4 |
(Deamino-Cys¹,β-cyclohexyl-Ala⁴,Arg⁸)-Vasopressin
|
0 |
C50H71N13O11S2 |
|
|
|
| GA20083-5mg |
|
43157-23-9 |
(Deamino-Cys¹,Val⁴,D-Arg⁸)-Vasopressin
|
0 |
C46H65N13O11S2 |
|
|
|
